Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.38%
SPX
-0.50%
IXIC
-0.50%
FTSE
-0.39%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

Insmed Showcases Advances in Respiratory Disease Treatment at ERS Congress 2025

3 days ago
publisher logo
Cashu

Insmed Boosts Talent Acquisition with Inducement Awards for 115 New Employees

18 days ago
publisher logo
Cashu

Insmed's Analyst Ratings Highlight Industry Complexity and Future Growth Potential

20 days ago

About

What does INSM do?
Insmed is a biopharmaceutical company based in Bridgewater, New Jersey, focusing on therapies for rare diseases, employing 912 staff. Its key products include ARIKAYCE, brensocatib, and TPIP for various lung diseases.
Sector
💻 Health Care
IPO
CEO
Employees
1,271
Headquarters
New Jersey, USA
Website
http://www.insmed.com

Key Stats

Market Cap
25.68B
Dividend Yield
0.00%
P/E Ratio
-24.83
EPS
-5.57
Revenue
363.71M
Avg. Volume
2.68M
Stocks
Health Care
insm
Insmed
NASDAQ: INSM
-5.46 (-3.87%)
135.54
USD
At close at Sep 25, 20:39 UTC
Summary
News
Signals
Benchmarks
Financials